Romiplostim 250microgram powder and solvent for solution for injection vials
NHS hospitals in England used £28,491,309 of indicative cost of Romiplostim 250microgram powder and solvent for solution for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 372.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Romiplostim 250microgram powder and solvent for solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Romiplostim 250microgram powder and solvent for solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpl B/Ham Nhs Foundation Trust | £1,173,188 |
| Manchester University Nhs Ft | £1,075,631 |
| South Tyneside And Sunderland Nhs Ft | £955,806 |
| University College London Foundation Tr | £952,914 |
| Royal Devon & Exeter Nhs Foundation Trst | £681,548 |
| Cambridge Univ Hosp Nhs Foundation Trust | £650,218 |
| Barts Health Nhs Trust | £642,988 |
| University Hospitals Dorset Nhs Ft | £593,342 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £516,704 |
| Royal Free London Nhs Foundation Trust | £514,294 |
The primary-care picture
Romiplostim is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Romiplostim medicine page.